Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Shimada

Showing results (191-200 of 295) with videos related to

Pageof 30
Sort By:
Surgery Today|November 14, 2015
Feasibility of neoadjuvant S-1 and oxaliplatin followed by surgery for resectable advanced gastric adenocarcinomaYoshitaka Honma, Yasuhide Yamada, Tetsuji Terazawa, et al.
The British Journal of Radiology|June 20, 2018
Imaging peritoneal metastasis of gastric cancer with <sup>18</sup>F-fluorothymidine positron emission tomography/computed tomography: a proof-of-concept studyYoshitaka Honma, Takashi Terauchi, Ukihide Tateishi, et al.
Clinical Colorectal Cancer|November 22, 2011
Safety analysis of FOLFOX4 treatment in colorectal cancer patients: a comparison between two Asian studies and four Western studiesKenichi Sugihara, Atsushi Ohtsu, Yasuhiro Shimada, et al.
Anticancer Research|April 12, 2015
Bevacizumab and postoperative wound complications in patients with liver metastases of colorectal cancerHirofumi Utsumi, Yoshitaka Honma, Kengo Nagashima, et al.
Anticancer Research|March 9, 2012
Phase I study of sunitinib plus modified FOLFOX6 in Japanese patients with treatment-naive colorectal cancerTakayuki Yoshino, Kentaro Yamazaki, Tetsuya Hamaguchi, et al.
Oncology|December 3, 2011
Phase II study of bolus 5-fluorouracil and leucovorin combined with weekly paclitaxel as first-line therapy for advanced gastric cancerJunichi Matsubara, Yasuhiro Shimada, Ken Kato, et al.
Oncotargets and Therapy|March 19, 2019
Everolimus for the treatment of advanced gastrointestinal or lung nonfunctional neuroendocrine tumors in East Asian patients: a subgroup analysis of the RADIANT-4 studyJames C Yao, Do-Youn Oh, Jiaming Qian, et al.
Esophagus : Official Journal of the Japan Esophageal Society|June 22, 2019
Gastric mucosal injury and hemorrhage after definitive chemoradiotherapy for locally advanced esophageal cancerSatoko Monma, Ken Kato, Hirokazu Shouji, et al.
Future Oncology (London, England)|May 13, 2015
The SOFT trial: a Phase III study of the dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 and oxaliplatin (SOX) plus bevacizumab as first-line chemotherapy for metastatic colorectal cancerMasato Nakamura, Yasuhide Yamada, Kei Muro, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 21, 2015
Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407)Tomohiro Nishina, Narikazu Boku, Masahiro Gotoh, et al.
Pageof 30

Showing results (191-200 of 295) with videos related to

Sort By:
Pageof 30
Surgery Today|November 14, 2015
Feasibility of neoadjuvant S-1 and oxaliplatin followed by surgery for resectable advanced gastric adenocarcinomaYoshitaka Honma, Yasuhide Yamada, Tetsuji Terazawa, et al.
The British Journal of Radiology|June 20, 2018
Imaging peritoneal metastasis of gastric cancer with <sup>18</sup>F-fluorothymidine positron emission tomography/computed tomography: a proof-of-concept studyYoshitaka Honma, Takashi Terauchi, Ukihide Tateishi, et al.
Clinical Colorectal Cancer|November 22, 2011
Safety analysis of FOLFOX4 treatment in colorectal cancer patients: a comparison between two Asian studies and four Western studiesKenichi Sugihara, Atsushi Ohtsu, Yasuhiro Shimada, et al.
Anticancer Research|April 12, 2015
Bevacizumab and postoperative wound complications in patients with liver metastases of colorectal cancerHirofumi Utsumi, Yoshitaka Honma, Kengo Nagashima, et al.
Anticancer Research|March 9, 2012
Phase I study of sunitinib plus modified FOLFOX6 in Japanese patients with treatment-naive colorectal cancerTakayuki Yoshino, Kentaro Yamazaki, Tetsuya Hamaguchi, et al.
Oncology|December 3, 2011
Phase II study of bolus 5-fluorouracil and leucovorin combined with weekly paclitaxel as first-line therapy for advanced gastric cancerJunichi Matsubara, Yasuhiro Shimada, Ken Kato, et al.
Oncotargets and Therapy|March 19, 2019
Everolimus for the treatment of advanced gastrointestinal or lung nonfunctional neuroendocrine tumors in East Asian patients: a subgroup analysis of the RADIANT-4 studyJames C Yao, Do-Youn Oh, Jiaming Qian, et al.
Esophagus : Official Journal of the Japan Esophageal Society|June 22, 2019
Gastric mucosal injury and hemorrhage after definitive chemoradiotherapy for locally advanced esophageal cancerSatoko Monma, Ken Kato, Hirokazu Shouji, et al.
Future Oncology (London, England)|May 13, 2015
The SOFT trial: a Phase III study of the dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 and oxaliplatin (SOX) plus bevacizumab as first-line chemotherapy for metastatic colorectal cancerMasato Nakamura, Yasuhide Yamada, Kei Muro, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 21, 2015
Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407)Tomohiro Nishina, Narikazu Boku, Masahiro Gotoh, et al.
Pageof 30